Cargando…

New Treatment Addressing the Pathogenesis of Psoriasis

Psoriasis is an immune cell-mediated inflammatory skin disease. The interleukin (IL)23/IL17 axis plays an important role in the development of psoriasis. The effectiveness of biologic treatments such as tumor necrosis factor (TNF)α inhibitors (infliximab, adalimumab, certolizumab pegol), IL23 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokuyama, Michio, Mabuchi, Tomotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589905/ https://www.ncbi.nlm.nih.gov/pubmed/33050592 http://dx.doi.org/10.3390/ijms21207488

Ejemplares similares

Psoriasis Pathogenesis and Treatment
por: Rendon, Adriana, et al.
Publicado: (2019)

New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
por: Ventura, Alessandra, et al.
Publicado: (2017)

Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
por: Kim, Hye One, et al.
Publicado: (2021)

Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment
por: Jain, Harsha, et al.
Publicado: (2021)

The Role of Adipokines in the Pathogenesis of Psoriasis
por: Kiełbowski, Kajetan, et al.
Publicado: (2023)

The Role of Sirtuins in the Pathogenesis of Psoriasis
por: Słuczanowska-Głabowska, Sylwia, et al.
Publicado: (2023)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

Skin-Resident Memory T Cells: Pathogenesis and Implication for the Treatment of Psoriasis
por: Vu, Trung T., et al.
Publicado: (2021)

The role of hormones in the pathogenesis of psoriasis vulgaris
por: ROMAN, IULIA IOANA, et al.
Publicado: (2016)

Adenosine: an endogenous mediator in the pathogenesis of psoriasis
por: Festugato, Moira
Publicado: (2015)

The Role of the Neutrophilic Network in the Pathogenesis of Psoriasis
por: Czerwińska, Joanna, et al.
Publicado: (2022)

Molecular Aspects of Pruritus Pathogenesis in Psoriasis
por: Jaworecka, Kamila, et al.
Publicado: (2021)

Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis
por: Pleńkowska, Joanna, et al.
Publicado: (2020)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis
por: Ferrari, Davide, et al.
Publicado: (2021)

Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy
por: Brożyna, Anna A., et al.
Publicado: (2022)

Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis
por: Burger, Beatriz, et al.
Publicado: (2023)

Effects of Neuropeptides on Dendritic Cells in the Pathogenesis of Psoriasis
por: Zhang, Jingya, et al.
Publicado: (2023)

Transcriptional regulation on effector T cells in the pathogenesis of psoriasis
por: Qu, Yuying, et al.
Publicado: (2023)

S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
por: Saito-Sasaki, Natsuko, et al.
Publicado: (2023)

Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study
por: Ohata, Chika, et al.
Publicado: (2023)

Advances in the pathogenesis of psoriasis: from keratinocyte perspective
por: Zhou, Xue, et al.
Publicado: (2022)

The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis
por: Yan, Bei, et al.
Publicado: (2020)

Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis
por: Bocheńska, Katarzyna, et al.
Publicado: (2020)

Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity
por: Honma, Masaru, et al.
Publicado: (2021)

Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review
por: Wu, Mengjun, et al.
Publicado: (2023)

Promising New Treatments for Psoriasis
por: Dubois Declercq, Sarah, et al.
Publicado: (2013)

Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Notch Signaling May Be Involved in the Abnormal Differentiation of Epidermal Keratinocytes in Psoriasis
por: Ota, Tami, et al.
Publicado: (2014)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis
por: Shen, Qian, et al.
Publicado: (2022)

CURRENT CONCEPTS IN THE PATHOGENESIS OF PSORIASIS
por: Das, Rajeev Patrick, et al.
Publicado: (2009)

Pathogenesis of Psoriasis: Focus on Autoinflammation
por: Marzano, Angelo Valerio, et al.
Publicado: (2018)

Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management
por: Haneke, Eckart
Publicado: (2017)

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives
por: Campanati, Anna, et al.
Publicado: (2017)

Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics
por: Petit, Robert Gironés, et al.
Publicado: (2021)

Role of Yes-Associated Protein in Psoriasis and Skin Tumor Pathogenesis
por: Jia, Jinjing, et al.
Publicado: (2022)

Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Special Issue “Pathogenesis, Epidemiology and Treatment of Atopic Dermatitis and Psoriasis”
por: Furue, Masutaka
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70uaep1ko100mc6sgtfkkbj42t